NASDAQ:BIOA BioAge Labs Q3 2025 Earnings Report $7.05 0.00 (0.00%) Closing price 09/25/2026 04:00 PM EasternExtended Trading$7.28 +0.23 (+3.26%) As of 09/25/2026 07:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast BioAge Labs EPS ResultsActual EPS-$0.56Consensus EPS -$0.67Beat/MissBeat by +$0.11One Year Ago EPSN/ABioAge Labs Revenue ResultsActual Revenue$2.05 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/ABioAge Labs Announcement DetailsQuarterQ3 2025Date11/6/2025TimeAfter Market ClosesConference Call DateThursday, November 6, 2025Conference Call Time4:00PM ETConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsEarnings Release(8-K)Quarterly Report(10-Q) BioAge Labs Earnings HeadlinesBioage Labs Inc (BIOA)September 26 at 4:00 AM | in.investing.comBioAge Labs to Present at Upcoming Investor ConferencesSeptember 25 at 4:30 PM | globenewswire.comFirst Look: Elon’s “Starphone”Rumors are swirling that Elon Musk is developing a new mobile device that could rival the iPhone. It's said to be thinner, longer-lasting on battery, and cheaper to produce, with the ability to work worldwide without relying on cell towers. Former Bloomberg reporter and SAC Capital trader Josh Baylin says the evidence is mounting. He notes the FCC recently gave Musk a green light connected to his mobile plans, adding fuel to speculation. Baylin previously called the smartphone boom in 2004 and predicted Apple would sell a billion phones when others expected a fraction of that. | Stansberry Research (Ad)Head to Head Analysis: BioAge Labs (NASDAQ:BIOA) and InMed Pharmaceuticals (NASDAQ:INM)September 24, 2026 | americanbankingnews.comFinancial Comparison: BioAge Labs (BIOA) versus Its CompetitorsSeptember 20, 2026 | americanbankingnews.comBioAge Labs (NASDAQ:BIOA) and Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Head-To-Head ContrastSeptember 20, 2026 | americanbankingnews.comSee More BioAge Labs Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like BioAge Labs? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioAge Labs and other key companies, straight to your email. Email Address About BioAge LabsBioAge Labs (NASDAQ:BIOA) (NASDAQ:BIOA) is a clinical-stage biotechnology company focused on developing medicines that target the biological mechanisms of aging. Its research uses human longevity data and proprietary computational biology tools to identify pathways associated with aging-related diseases and to develop potential therapies aimed at extending healthy lifespan and improving physical function. The company’s lead investigational program is azelaprag, also known as BGE-105, an oral small-molecule apelin receptor agonist being studied for its potential to preserve muscle mass and improve physical performance in older adults. BioAge is also evaluating its broader pipeline in areas such as obesity, metabolic disease, muscle health and immune function, although its programs remain in clinical development and have not been approved for commercial use. BioAge was founded in 2015 and is headquartered in Richmond, California. The company’s operations are centered on research, drug discovery and clinical development, with studies conducted in collaboration with clinical and research organizations. Kristen Fortney, Ph.D., is the company’s co-founder, president and chief executive officer.View BioAge Labs ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 09/21 - 09/252 Cybersecurity Stocks Breaking Out as AI Continues to Be a TailwindCostco Ends Its Fiscal Year on a High Note, Eyes Big ExpansionCracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic Problem5 Scary-Good Stocks With Strong October Catalysts and Breakout PotentialDarden Restaurants Serves Up Fresh Catalysts for a Stock Price RallySoFi Is Bypassing the Banking Bottleneck With Stablecoin Settlement Upcoming Earnings Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
